Discipline-specific open access publishing practices and barriers to change: an evidence-based review [version 2; peer review: 2 approved, 1 approved with reservations]
Severin, Anna, Egger, Matthias, Eve, Martin Paul, Hürlimann, Daniel
Published in F1000 research (2020)
Published in F1000 research (2020)
Get full text
Journal Article
CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
ANDERSON, Victoria E, WALTON, Michael I, GARRETT, Michelle D, EVE, Paul D, BOXALL, Katherine J, ANTONI, Laurent, CALDWELL, John J, AHERNE, Wynne, PEARL, Laurence H, OLIVER, Antony W, COLLINS, Ian
Published in Cancer research (Chicago, Ill.) (15.01.2011)
Published in Cancer research (Chicago, Ill.) (15.01.2011)
Get full text
Journal Article
CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
WALTON, Mike I, EVE, Paul D, MATTHEWS, Thomas P, JAMIN, Yann, ROBINSON, Simon P, WYNNEAHERNE, G, READER, John C, CHESLER, Louis, RAYNAUD, Florence I, ECCLES, Suzanne A, COLLINS, Ian, GARRETT, Michelle D, HAYES, Angela, VALENTI, Melanie R, DE HAVEN BRANDON, Alexis K, BOX, Gary, HALLSWORTH, Albert, SMITH, Elizabeth L, BOXALL, Kathy J, LAINCHBURY, Michael
Published in Clinical cancer research (15.10.2012)
Published in Clinical cancer research (15.10.2012)
Get full text
Journal Article
Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
Walters, Zoë S, Aladowicz, Ewa, Villarejo-Balcells, Barbara, Nugent, Gary, Selfe, Joanna L, Eve, Paul, Blagg, Julian, Rossanese, Olivia, Shipley, Janet
Published in Cancers (06.04.2021)
Published in Cancers (06.04.2021)
Get full text
Journal Article
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays
Le Bihan, Yann-Vaï, Lanigan, Rachel M., Atrash, Butrus, McLaughlin, Mark G., Velupillai, Srikannathasan, Malcolm, Andrew G., England, Katherine S., Ruda, Gian Filippo, Mok, N. Yi, Tumber, Anthony, Tomlin, Kathy, Saville, Harry, Shehu, Erald, McAndrew, Craig, Carmichael, LeAnne, Bennett, James M., Jeganathan, Fiona, Eve, Paul, Donovan, Adam, Hayes, Angela, Wood, Francesca, Raynaud, Florence I., Fedorov, Oleg, Brennan, Paul E., Burke, Rosemary, van Montfort, Rob L.M., Rossanese, Olivia W., Blagg, Julian, Bavetsias, Vassilios
Published in European journal of medicinal chemistry (01.09.2019)
Published in European journal of medicinal chemistry (01.09.2019)
Get full text
Journal Article
AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
YAP, Timothy A, WALTON, Mike I, HEINZMANN, Kathrin, JONES, Paul S, FELTELL, Ruth E, REULE, Matthias, WOODHEAD, Steven J, DAVIES, Thomas G, LYONS, John F, RAYNAUD, Florence I, ECCLES, Suzanne A, WORKMAN, Paul, GRIMSHAW, Kyla M, THOMPSON, Neil T, GARRETT, Michelle D, TE POELE, Robert H, EVE, Paul D, VALENTI, Melanie R, DE HAVEN BRANDON, Alexis K, MARTINS, Vanessa, ZETTERLUND, Anna, HEATON, Simon P
Published in Clinical cancer research (15.07.2012)
Published in Clinical cancer research (15.07.2012)
Get full text
Journal Article
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930
Yap, Timothy A, Walton, Mike I, Hunter, Lisa-Jane K, Valenti, Melanie, de Haven Brandon, Alexis, Eve, Paul D, Ruddle, Ruth, Heaton, Simon P, Henley, Alan, Pickard, Lisa, Vijayaraghavan, Gowri, Caldwell, John J, Thompson, Neil T, Aherne, Wynne, Raynaud, Florence I, Eccles, Suzanne A, Workman, Paul, Collins, Ian, Garrett, Michelle D
Published in Molecular cancer therapeutics (01.02.2011)
Published in Molecular cancer therapeutics (01.02.2011)
Get full text
Journal Article